The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives Toshiyuki HamaokaYasuyuki TakaiHiromi Fujiwara Original Articles Pages: 183 - 188
Modulation of natural killer activity by thymosin alpha 1 and interferon Cartesio FavalliTeresa JezziEnrico Garaci Original Articles Pages: 189 - 192
A phase I trial of recombinant gamma interferon in patients with cancer Kenneth A. FoonStephen A. SherwinRonald B. Herberman Original Articles Pages: 193 - 197
Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: Characterization of the effector population and evidence for the role of the host's non-T cells Mario P. ColomboMariella ParenzaGiorgio Parmiani Original Articles Pages: 198 - 204
The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages Simcha MarcovitchYona Keisari Original Articles Pages: 205 - 208
Effect of melphalan in vitro on induction of murine suppressor T cells by ConA Rachel OphirShlomo Ben-Efraim Original Articles Pages: 209 - 213
The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo Terry L. BowlinAndrea L. RosenbergerPrasad S. Sunkara Original Articles Pages: 214 - 218
Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma Wim MisdorpWim R. KleinPeter A. Steerenberg Original Articles Pages: 223 - 230
Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma analysis at the eighth year Hiroshi TakitaAriel HollinsheadMichael Ramundo Original Articles Pages: 231 - 235
Treatment of patients with transitional cell carcinoma of the urinary bladder with intravesical poly I: Poly C effects on natural killer function C. MorozB. KupferM. Many Original Articles Pages: 236 - 240
